These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 12926132)
21. Irinotecan, oxaliplatin, and 5-fluorouracil/leucovorin combination chemotherapy in advanced colorectal carcinoma: a phase II study. Calvo E; Cortés J; Rodríguez J; Fernández-Hidalgo O; Rebollo J; Martín-Algarra S; García-Foncillas J; Martínez-Monge R; de Irala J; Brugarolas A Clin Colorectal Cancer; 2002 Aug; 2(2):104-10. PubMed ID: 12453325 [TBL] [Abstract][Full Text] [Related]
22. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. de Gramont A; Bosset JF; Milan C; Rougier P; Bouché O; Etienne PL; Morvan F; Louvet C; Guillot T; François E; Bedenne L J Clin Oncol; 1997 Feb; 15(2):808-15. PubMed ID: 9053508 [TBL] [Abstract][Full Text] [Related]
23. An alternating regimen of irinotecan/ 5-fluorouracil/folinic acid and oxaliplatin/ 5-fluorouracil/folinic acid in metastatic colorectal cancer: a Phase II trial. Ferrari V; Valcamonico F; Amoroso V; Simoncini E; Vassalli L; Marpicati P; Rangoni G; Grisanti S; Pasinetti N; Marini G Oncology; 2005; 69(4):283-9. PubMed ID: 16282707 [TBL] [Abstract][Full Text] [Related]
24. Phase I/II study of irinotecan, 5-fluorouracil, and l-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancer. Goto A; Yamada Y; Hosokawa A; Ura T; Arai T; Hamaguchi T; Muro K; Shimada Y; Shirao K Int J Clin Oncol; 2004 Oct; 9(5):364-8. PubMed ID: 15549585 [TBL] [Abstract][Full Text] [Related]
25. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer. Kemeny N; Garay CA; Gurtler J; Hochster H; Kennedy P; Benson A; Brandt DS; Polikoff J; Wertheim M; Shumaker G; Hallman D; Burger B; Gupta S J Clin Oncol; 2004 Dec; 22(23):4753-61. PubMed ID: 15570076 [TBL] [Abstract][Full Text] [Related]
26. Biweekly oxaliplatin plus irinotecan and folinic acid-modulated 5-fluorouracil: a phase II study in pretreated patients with metastatic colorectal cancer. Comella P; Massidda B; Palmeri S; Putzu C; De Rosa V; Izzo F; Fiore F; Casaretti R; Sandomenico C Anticancer Drugs; 2006 Sep; 17(8):985-92. PubMed ID: 16940809 [TBL] [Abstract][Full Text] [Related]
27. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study. Taïeb J; Artru P; Paye F; Louvet C; Perez N; André T; Gayet B; Hebbar M; Goebel FM; Tournigand C; Parc R; de Gramont A J Clin Oncol; 2005 Jan; 23(3):502-9. PubMed ID: 15659495 [TBL] [Abstract][Full Text] [Related]
28. Phase I study of a weekly schedule of irinotecan, high-dose leucovorin, and infusional fluorouracil as first-line chemotherapy in patients with advanced colorectal cancer. Vanhoefer U; Harstrick A; Köhne CH; Achterrath W; Rustum YM; Seeber S; Wilke H J Clin Oncol; 1999 Mar; 17(3):907-13. PubMed ID: 10071283 [TBL] [Abstract][Full Text] [Related]
29. Irinotecan in combination with fluorouracil in a 48-hour continuous infusion as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors study. Sastre J; Marcuello E; Masutti B; Navarro M; Gil S; Antón A; Abad A; Aranda E; Maurel J; Valladares M; Maestu I; Carrato A; Vicent JM; Díaz-Rubio E; J Clin Oncol; 2005 May; 23(15):3545-51. PubMed ID: 15908665 [TBL] [Abstract][Full Text] [Related]
30. Multicentre phase II study of bifractionated CPT-11 with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer pretreated with FOLFOX. Recchia F; Saggio G; Nuzzo A; Lalli A; Lullo LD; Cesta A; Rea S Br J Cancer; 2004 Oct; 91(8):1442-6. PubMed ID: 15467766 [TBL] [Abstract][Full Text] [Related]
31. [Phase I study of CPT-11 and continuous 5-FU / l-leucovorin combination therapy(modified AIO regimen)in patients with metastatic colorectal cancer]. Nakamura T; Kurachi K; Fukazawa A; Hayashi T; Nakamura K; Nakajima A; Suzuki S; Konno H Gan To Kagaku Ryoho; 2008 Oct; 35(10):1697-701. PubMed ID: 18931571 [TBL] [Abstract][Full Text] [Related]
32. Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer. Teufel A; Steinmann S; Siebler J; Zanke C; Hohl H; Adami B; Schroeder M; Klein O; Höhler T; Galle PR; Heike M; Moehler M BMC Cancer; 2004 Jul; 4():38. PubMed ID: 15265233 [TBL] [Abstract][Full Text] [Related]
33. Phase II trial of a biweekly regimen of fluorouracil and leucovorin plus irinotecan in patients with previously untreated advanced gastric cancer. Rosati G; Cordio S; Caputo G; Condorelli S; Germano D; Mattina M; Amadio P; Reggiardo G; Manzione L J Chemother; 2007 Oct; 19(5):570-6. PubMed ID: 18073157 [TBL] [Abstract][Full Text] [Related]
34. 5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: a multicenter randomised phase II study of the Southern Italy Oncology Group. Maiello E; Gebbia V; Giuliani F; Paoletti G; Gebbia N; Cigolari S; Fortunato S; Pedicini T; Borsellino N; Lopez M; Colucci G Ann Oncol; 2000 Aug; 11(8):1045-51. PubMed ID: 11038044 [TBL] [Abstract][Full Text] [Related]
35. A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma. Rothenberg ML; Cox JV; DeVore RF; Hainsworth JD; Pazdur R; Rivkin SE; Macdonald JS; Geyer CE; Sandbach J; Wolf DL; Mohrland JS; Elfring GL; Miller LL; Von Hoff DD Cancer; 1999 Feb; 85(4):786-95. PubMed ID: 10091755 [TBL] [Abstract][Full Text] [Related]
36. Multicenter phase II study of irinotecan plus bolus fluorouracil/l-leucovorin for metastasic colorectal cancer. Mishima H; Ikenaga M; Ishida H; Iwamoto S; Morimoto T; Narahara H; Kato T; Tsujie M; Kitai T; Fukunaga M; Nakanishi M; Tsujinaka T; Furukawa H; Taguchi T; Anticancer Res; 2007; 27(2):1003-8. PubMed ID: 17465234 [TBL] [Abstract][Full Text] [Related]
37. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer. Klaassen U; Wilke H; Seeber S Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897 [TBL] [Abstract][Full Text] [Related]
38. Decreasing dosage of irinotecan, 5-flurouracil (5-FU) and leucovorin (LV) in the treatment of advanced and/or metastatic colorectal cancer: a phase II study. Huang JS; Yen CL; You YT; Wang CH; Lan YJ; Lai CH; Chueh TC; Liaw CC Chang Gung Med J; 2006; 29(3):297-305. PubMed ID: 16924892 [TBL] [Abstract][Full Text] [Related]
39. Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high-dose leucovorin every two weeks (LV5FU2 regimen): a clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancer. Ducreux M; Ychou M; Seitz JF; Bonnay M; Bexon A; Armand JP; Mahjoubi M; Méry-Mignard D; Rougier P J Clin Oncol; 1999 Sep; 17(9):2901-8. PubMed ID: 10561369 [TBL] [Abstract][Full Text] [Related]
40. A phase II study of irinotecan, continuous 5-fluorouracil, and leucovorin (FOLFIRI) combination chemotherapy for patients with recurrent or metastatic gastric cancer previously treated with a fluoropyrimidine-based regimen. Kim SH; Lee GW; Go SI; Cho SH; Kim HJ; Kim HG; Kang JH Am J Clin Oncol; 2010 Dec; 33(6):572-6. PubMed ID: 20042971 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]